Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • PB2586: PASSIVE PREEXPOSURE IM...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY

PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY

Bibliographic Details
Main Authors: Caterina Buquicchio, Jon Salmanton-García, Francesco Marchesi, Federico Itri, Caroline Besson, Sonia Martín-Pérez, Julio Dávila-Valls, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Jorge Labrador, Raul Cordoba, Alberto Lopez-Garcia, Nicola Stefano Fracchiolla, Francesca Farina, Oliver A. Cornely, Livio Pagano
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000977036.45003.69
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000977036.45003.69

Similar Items

  • Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
    by: Francesco Marchesi, et al.
    Published: (2023-04-01)
  • Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy
    by: M. V. Zhuravleva, et al.
    Published: (2023-07-01)
  • A case of prolonged COVID‐19 treated with tixagevimab/cilgavimab
    by: Takahiro Shimizu, et al.
    Published: (2023-03-01)
  • Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era.
    by: Benjamin Chen, et al.
    Published: (2023-01-01)
  • Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
    by: Benjamin Chen, et al.
    Published: (2023-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs